Media formats available:
Recommended
- CDMC 2018: Shifting gears in the management of diabetes and CVDTranslating mechanisms of GLP-1RAs and SGLT2 inhibitors to CV benefits
Dr. Adie Viljoen, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: The GLP1 landscape - refining our understanding
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Diabetes: The new challenge in cardiovascular risk management
Prof. Lars Rydén
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Translating mechanisms to benefits: How can we explain the cardiovascular benefits of new diabetes drugs?